Colistin-tigecycline versus colistin-imipenem-cilastatin combinations for the treatment of Acinetobacter baumannii ventilator-acquired pneumonia: a prognosis study.
Department of Intensive Care, Habib Bourguiba University Hospital, Faculty of Medicine, Road El Ain km 0.5, 3029, Sfax, Tunisia. anischaari2004@yahoo.fr.
Anis
A
Chaari
AP-HP, Hôpital Tenon, Unité de Réanimation médico-chirurgicale, Pôle Thorax Voies aériennes, Groupe hospitalier des Hôpitaux Universitaires de L'Est Parisien, Hôpital Tenon, 4 rue de la Chine, 75020, Paris Cedex 20, France.|UMR 1153, Inserm, Sorbonne Paris Cité, ECSTRA Team, Université Paris Diderot, Paris, France.|UMR 915, Inserm, Université Paris Est Créteil, Créteil, France.
Tài
T
Pham
Department of Microbiology, Habib Bourguiba University Hospital, Faculty of Medicine, Sfax, Tunisia.
Basma
B
Mnif
Department of Intensive Care, Habib Bourguiba University Hospital, Faculty of Medicine, Road El Ain km 0.5, 3029, Sfax, Tunisia.
Kamilia
K
Chtara
Department of Intensive Care, Habib Bourguiba University Hospital, Faculty of Medicine, Road El Ain km 0.5, 3029, Sfax, Tunisia.
Fatma
F
Medhioub
Department of Intensive Care, Habib Bourguiba University Hospital, Faculty of Medicine, Road El Ain km 0.5, 3029, Sfax, Tunisia.
Najeh
N
Baccouche
Department of Intensive Care, Habib Bourguiba University Hospital, Faculty of Medicine, Road El Ain km 0.5, 3029, Sfax, Tunisia.
Mabrouk
M
Bahloul
Department of Microbiology, Habib Bourguiba University Hospital, Faculty of Medicine, Sfax, Tunisia.
Adnène
A
Hammami
Department of Intensive Care, Habib Bourguiba University Hospital, Faculty of Medicine, Road El Ain km 0.5, 3029, Sfax, Tunisia.
Mounir
M
Bouaziz
D000151:Acinetobacter Infections / Q000188:drug therapy* / Q000401:mortality; D040981:Acinetobacter baumannii / Q000187:drug effects*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015377:Cilastatin / Q000008:administration & dosage / Q000627:therapeutic use*; D000077728:Cilastatin, Imipenem Drug Combination; D003091:Colistin / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D024901:Drug Resistance, Multiple, Bacterial / Q000187:drug effects; D006801:Humans; D015378:Imipenem / Q000008:administration & dosage / Q000627:therapeutic use*; D008911:Minocycline / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D053717:Pneumonia, Ventilator-Associated / Q000188:drug therapy* / Q000382:microbiology / Q000401:mortality; D011379:Prognosis; D012189:Retrospective Studies; D016879:Salvage Therapy; D016019:Survival Analysis; D000078304:Tigecycline; D014416:Tunisia / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D015377:Cilastatin; D000078304:Tigecycline; D015378:Imipenem; D000077728:Cilastatin, Imipenem Drug Combination; D008911:Minocycline; D003091:Colistin